# Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer

> **NCT06641635** · PHASE3 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 440 (estimated)

## Conditions studied

- Cervical Cancer
- Adaptive Radiotherapy

## Interventions

- **COMBINATION_PRODUCT:** Moderated hypofractionated online adaptive radiotherapy
- **COMBINATION_PRODUCT:** Conventional radiotherapy

## Key facts

- **NCT ID:** NCT06641635
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-19
- **Primary completion:** 2026-10-31
- **Final completion:** 2029-10-31
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2025-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06641635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06641635, "Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06641635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*